Entia Biosciences, Inc.
ERGO
$0.0001
-$0.0001-50.00%
12/31/2016 | 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 76.10K | 2.00K | 17.80K | -- | 24.10K |
Total Receivables | 8.00K | 5.70K | 10.00K | 9.50K | 7.10K |
Inventory | 69.80K | 28.70K | 13.10K | 31.20K | 40.30K |
Prepaid Expenses | 80.60K | 36.20K | 41.10K | 45.00K | 56.80K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 234.30K | 72.60K | 81.90K | 85.70K | 128.30K |
|
|||||
Total Current Assets | 234.30K | 72.60K | 81.90K | 85.70K | 128.30K |
Net Property, Plant & Equipment | 18.30K | 21.80K | 25.40K | 29.10K | 32.70K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 186.50K | 236.40K | 237.50K | 236.00K | 232.60K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | 35.00K | 55.00K | 55.00K | 55.00K |
Total Assets | 439.10K | 365.80K | 399.80K | 405.80K | 448.60K |
|
|||||
Total Accounts Payable | 652.70K | 691.30K | 659.20K | 616.20K | 595.30K |
Total Accrued Expenses | 707.10K | 758.90K | 635.90K | 454.70K | 365.30K |
Short-term Debt | 734.60K | 254.20K | 193.30K | 208.70K | 279.20K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 11.40K | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | 6.30K | 4.20K | -- | -- |
Total Other Current Liabilities | -- | 6.30K | 4.20K | -- | -- |
Total Current Liabilities | 2.11M | 1.71M | 1.49M | 1.28M | 1.24M |
|
|||||
Total Current Liabilities | 2.11M | 1.71M | 1.49M | 1.28M | 1.24M |
Long-Term Debt | 300.10K | 298.60K | 297.20K | 152.80K | -- |
Short-term Debt | 734.60K | 254.20K | 193.30K | 208.70K | 279.20K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 2.41M | 2.01M | 1.79M | 1.43M | 1.24M |
|
|||||
Common Stock & APIC | 12.51M | 12.42M | 12.39M | 12.36M | 12.34M |
Retained Earnings | -14.47M | -14.04M | -13.75M | -13.35M | -13.08M |
Treasury Stock & Other | -8.90K | -18.80K | -29.90K | -40.90K | -51.90K |
Total Common Equity | -1.97M | -1.64M | -1.39M | -1.03M | -791.40K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 200.00 | 200.00 | 200.00 | 200.00 | 200.00 |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 200.00 | 200.00 | 200.00 | 200.00 | 200.00 |
|
|||||
Total Common Equity | -1.97M | -1.64M | -1.39M | -1.03M | -791.40K |
Total Preferred Equity | 200.00 | 200.00 | 200.00 | 200.00 | 200.00 |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -1.97M | -1.64M | -1.39M | -1.03M | -791.20K |
|